Related Experiment Video
Updated: Jun 26, 2026

Postmortem Diagnosis of Rabies in Animals by the Updated, Multiplexed LN34 Real-Time Reverse Transcription-Polymerase Chain Reaction Assay
Published on: May 2, 2025
Increased public and clinician awareness of rabies after UK death
Aims:
To identify trends within rabies Post Exposure Treatment (PET) product use for 2025 compared with previous years and highlight potential underlying causes.
Methods:
Data from the National Immunisation Office (NIO) was analysed retrospectively. The years 2020-2022 had low ordering due to COVID-19 so the years 2019, 2023 and 2024 were averaged in a 'baseline year'. Statistical analyses calculated absolute and percentage increases of rabies PET product use in 2025 compared to previous years.
Results:
Ireland saw a sharp increase of 643 units (249%) in rabies vaccine and 103 units (368%) Human Rabies Immunoglobulin (HRIG) use in 2025 compared to the baseline year.
Conclusion:
This trend may be associated with heightened clinician and public awareness of rabies prone exposure (RPE) and recent changes to service delivery. External factors including resurgence of travel following COVID-19, a UK rabies related death in June 2025 and global rabies product shortage may compound this.
More Related Videos
Related Concept Videos
Rabies
Rocky Mountain Spotted Fever
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Toxoplasmosis
Arboviral Encephalitis
Vaccinations

